For middle-aged women with restless legs syndrome, it's not just itching and an irresistible urge to move the legs. It also may be a risk factor for high blood pressure.

The discovery of key brain receptors gives researchers new ammunition in finding new and innovative ways to treat Alzheimer's disease and disability from stroke.

For many Alzheimer's patients, the disease slowly erodes brain cognition. Others aren't so lucky and the decline can be rapid. The problem is there's been no way to identify those that quickly decline and need aggressive treatment.

The sooner you treat a disease like multiple sclerosis (MS), the better the outcome, right? Well, that statement appears to be somewhat true.

In a small preliminary study the drug gantenerumab appears to reduce amyloid levels in the brains of patients with Alzheimer's disease.

For patients with essential tremor, characterized by involuntary shaking often associated with Parkinson's disease, a brain tumor or epilepsy, the effects can be embarrassing and make work and daily activities difficult.

It is good news when researchers gain a little more knowledge about the development of one disease. It is even better news when that little bit of knowledge applies to a whole group of diseases.

The dietary supplement glucosamine is popular for helping aching, arthritic joints. A new supplement looks like it could suppress the damaging autoimmune response seen in multiple sclerosis (MS).

Pain will come and go for most people, but it can be more intense if you suffer depression and/or anxiety. Treating these problems can be difficult but experts provide some tips.